ArticleOrphanet journal of rare diseases2025
Long-term efficacy and safety of low-dose rituximab strategy in neuromyelitis optica spectrum disorder: a retrospective cohort study on treatment compliance and clinical outcomes.
Yao Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.